Market Feasibility helps test patient reach, understanding, and qualification signals earlier. Your patients don’t see a protocol. They see a headline, an image, a landing page, a screener question, a call, and a decision: Is this worth my time? That first interaction shapes what they understand before a site ever speaks with them. It tells them whether the study feels relevant, credible, and clear enough to continue. That gap matters because clinical trial recruitment doesn’t only compete for attention. It competes for understanding. A protocol can define eligibility, sites, timelines, and endpoints. But patients make choices based on the version of the study placed in front of them. If that version feels vague, overly clinical, or disconnected from how patients think, early response becomes harder to trust. Patients need to understand quickly: Is this relevant to me? Do I understand what it’s asking? Does it feel credible? Is the next step clear? Am I likely to qualify? When the message is unclear, a campaign can still generate clicks. But clicks alone don’t prove recruitment readiness.